We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
(-12%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
59
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$49.5M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$21.8M |
| 3 |
Walt Disney
DIS
|
+$16.1M |
| 4 |
Microsoft
MSFT
|
+$11M |
| 5 |
TSMC
TSM
|
+$8.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$6.55M |
| 2 |
Bausch Health
BHC
|
+$5.35M |
| 3 |
Digital Realty Trust
DLR
|
+$1.95M |
| 4 |
PennyMac Financial
PFSI
|
+$1.67M |
| 5 |
ConocoPhillips
COP
|
+$1.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 7.31% |
| 2 | Communication Services | 4.95% |
| 3 | Technology | 3.75% |
| 4 | Energy | 1.57% |
| 5 | Healthcare | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
SIGA Technologies
SIGA
$240M
| $193K | 0.03% |
+18,700
| New | +$300K |
|
202
CALL
ADT
ADT
$5.43B
| $187K | 0.03% |
+25,000
| New | +$188K |
|
203
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
| $182K | 0.02% |
+2,300
| New | +$194K |
|
204
Sociedad Química y Minera de Chile
SQM
$19.3B
| $182K | 0.02% |
+2,000
| New | +$194K |
|
205
CALL
TG Therapeutics
TGTX
$8.19B
| $177K | 0.02% |
29,900
| – | – |
|
206
CALL
Snap
SNAP
$7.96B
| $172K | 0.02% |
17,500
-37,500
| -68% | -$436K |
|
207
PUT
Viatris
VTRS
$20.8B
| $170K | 0.02% |
20,000
-10,000
| -33% | -$98.4K |
|
|
SGMO
208
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $170K | 0.02% |
+34,700
| New | +$178K |
|
|
SGMO
209
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $161K | 0.02% |
+32,800
| New | +$168K |
|
210
Avita Medical
RCEL
$137M
| $156K | 0.02% |
29,650
-2,350
| -7% | -$14.5K |
|
|
MDRX
211
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $152K | 0.02% |
+10,000
| New | +$162K |
|
|
TELL
212
DELISTED
Tellurian Inc.
TELL
| $143K | 0.02% |
60,000
-15,000
| -20% | -$54.1K |
|
|
TELL
213
PUT
DELISTED
Tellurian Inc.
TELL
| $143K | 0.02% |
60,000
| – | – |
|
214
Mercado Libre
MELI
$94.5B
| $142K | 0.02% |
172
+122
| +244% | +$105K |
|
|
VERV
215
DELISTED
Verve Therapeutics
VERV
| $137K | 0.02% |
+4,000
| New | +$128K |
|
216
CALL
UWM Holdings
UWMC
$672M
| $130K | 0.02% |
44,400
| – | – |
|
|
217
Viatris
VTRS
$20.8B
| $128K | 0.02% |
15,000
-5,000
| -25% | -$49.2K |
|
218
Procter & Gamble
PG
$340B
| $126K | 0.02% |
+1,000
| New | +$142K |
|
|
219
PUT
Avita Medical
RCEL
$137M
| $124K | 0.02% |
23,500
| – | – |
|
220
PUT
Antero Resources
AR
$10.9B
| $122K | 0.02% |
+4,000
| New | +$148K |
|
221
PUT
Gossamer Bio
GOSS
$101M
| $120K | 0.02% |
10,000
-10,000
| -50% | -$124K |
|
|
NNDM
222
Nano Dimension
NNDM
$314M
| $120K | 0.02% |
50,000
| – | – |
|
223
SiTime
SITM
$13.8B
| $118K | 0.02% |
+1,500
| New | +$193K |
|
|
PLYA
224
CALL
DELISTED
Playa Hotels & Resorts
PLYA
| $116K | 0.02% |
20,000
| – | – |
|
225
CALL
DaVita
DVA
$15.5B
| $116K | 0.02% |
1,400
-9,600
| -87% | -$842K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q3 2022 Portfolio in Review
As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
SG3 Management withdrew a net $67.1M in Q3 2022, closing 238 positions and reducing 59 holdings. Its most notable exit was KraneShares CSI China Internet ETF, an estimated $6.55M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 7.3% of assets, up from 0.21% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Tesla worth $47M.
- SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
- SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
- SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
- SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
- SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
- SG3 Management opened 122 new positions and closed 238 in Q3 2022.
- SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.
Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.